Somerset, N.J. – February 2, 2015 — Catalent Pharma Solutions (Booth 1611), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, will deliver a presentation on Catalent’s recent acquisition of market leading particle size engineering company, Micron Technologies, at the InformEx tradeshow, to be held at the Morial Convention Center, New Orleans, LA, between February 3rd and 5th, 2015.
The showcase, to be held at 9.20 am on Tuesday February 3rd, in Room 222, will be given by Michael McDougal, Director, Business Development at Micron Technologies.
Particle size engineering techniques, such as micronization, enable effective and cost-efficient particle reduction of crystalline formulations, which can aid solubility of compounds and improve the uniform distribution of API within formulations. Particle size is inherently linked to dissolution and absorption rates of APIs within the body and both are fundamental to the performance of a drug product.
Catalent acquired Micron Technologies in November 2014, expanding the company’s bioavailability and solubility services offer. With the addition of particle size engineering expertise and experience, Catalent can now help clients at the earliest stages of the drug development process and provide end-to-end solutions to accelerate programs to clinic and market with an unrivalled set of bioavailability solutions in its toolkit.